Lotronex (alosetron), a new drug for irritable bowel syndrome (IBS)

Glaxo is now starting to promote Lotronex (alosetron), a new drug for irritable bowel syndrome (IBS).

This will be big.

Approx 30 million Americans have irritable bowel syndrome...it's three times more common in women than in men.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote